PodParley PodParley
PodParley
MPR Weekly Dose 66 - The Moderna vaccine's efficacy against new variants; Merck ends development of new vaccines; Antiviral treatment combos show promise; New lupus nephritis treatment episode artwork

EPISODE · Jan 28, 2021 · 12 MIN

MPR Weekly Dose 66 - The Moderna vaccine's efficacy against new variants; Merck ends development of new vaccines; Antiviral treatment combos show promise; New lupus nephritis treatment

from MPR Weekly Dose

On this week's pod: The Moderna vaccine and what we know about its effectiveness against emerging variants; Merck ends it's development of two vaccines; Two separate treatment combos show promise in reducing hospitalizations and preventing COVID, respectivel; And the FDA approve a new treatment for lupus nephritis. 

Episode metadata supplied by the publisher feed · Published Jan 28, 2021

Embed this episode

Ready to play

MPR Weekly Dose 66 - The Moderna vaccine's efficacy against new variants; Merck ends development of new vaccines; Antiviral treatment combos show promise; New lupus nephritis treatment

0:00 12:22

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MPR Weekly Dose?

This episode is 12 minutes long.

When was this MPR Weekly Dose episode published?

This episode was published on January 28, 2021.

Can I download this MPR Weekly Dose episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!